Filing Flows › Guardian Pharmacy Services (GRDN) › Q2 2026 › vs Q1 2026
Guardian Pharmacy Services (GRDN) Q2 2026 vs Q1 2026 (quarter over quarter)
Guardian Pharmacy Services's revenue rose $15.2M (+5%) from $337M in Q1 2026 to $352M in Q2 2026. Gross margin 22.8% against 22.7% (+0.1 pts).
Guardian Pharmacy Services, Q2 2026: revenue $352M (+2% year over year), operating margin 5.9%, net earnings $22.1M, operating cash flow $30.0M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 22.8% | 22.7% | +0.1 pts |
| Operating margin | 5.9% | 5.3% | +0.6 pts |
| Net margin | 6.3% | 4.0% | +2.3 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $352M | $337M | $15.2M | +5% |
| Gross profit | $80.0M | $76.3M | $3.7M | +5% |
| Cost of revenue | $272M | $260M | $11.4M | +4% |
| Other income, net | $9.1M | $618K | $8.5M | 15× |
| Operating profit | $20.6M | $17.7M | $3.0M | +17% |
| Operating expenses | $59.4M | $58.6M | $766K | +1% |
| Pre-tax earnings | $29.8M | $18.3M | $11.5M | +63% |
| Net earnings | $22.1M | $13.5M | $8.6M | +63% |
| Income tax | $7.7M | $4.7M | $2.9M | +62% |
| Depreciation & amortization | $5.8M | $6.0M | −$168K | -3% |
| Share-based compensation | $2.9M | $1.9M | $1.1M | +58% |
| Working capital & other | $836K | $15.3M | −$14.5M | -95% |
| Operating cash flow | $30.0M | $6.1M | $24.0M | +395% |
Questions
How much did Guardian Pharmacy Services's revenue grow quarter over quarter in Q2 2026?
Guardian Pharmacy Services's revenue rose $15.2M (+5%) from $337M in Q1 2026 to $352M in Q2 2026. Gross margin 22.8% against 22.7% (+0.1 pts).